MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DOLLY, JO. O.
Right arrow Articles by BARNARD, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOLLY, JO. O.
Right arrow Articles by BARNARD, E. A.

Molecular Pharmacology, Vol 13, 1-14, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Binding of Perhydro-histrionicotoxin to the Postsynaptic Membrane of Skeletal Muscle in Relation to Its Blockade of Acetylcholine-Induced Depolarization

JO. O. DOLLY 1, E. X. ALBUQUERQUE 1, J. M. SARVEY 1, B. MALLICK 1, and E. A. BARNARD 1

1 Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201, and Department of Biochemistry, State University of New York at Buffalo, Buffalo, New York 14214

Perhydro-histrionicotoxin (H12-HTX), a potent neuromuscular blocking agent, was investigated as a potential probe for conductance systems associated with the acetylcholine receptor. In rat muscles, H12-HTX blocked the end plate potential and also the extrajunctional acetylcholine sensitivity, with half-maximal effects seen at about 8.4 µM and 2.4 µM, respectively. The retardation of agr-bungarotoxin binding to denervated muscle membranes by increasing concentrations of H12-HTX showed a noncompetitive type of behavior, with the half-maximal effect at concentrations of H12-HTX much higher than needed to block the acetylcholine response. The binding of H12-HTX, as detected by this protection from agr-bungarotoxin, was essentially the same in the membrane and in the pure, soluble receptor. H12-HTX at sufficient concentrations could block 90-100% of the bungarotoxin binding sites; the same was true for d-tubocurarine, confirming that these are the receptor sites, in both innervated and denervated muscle preparations. Measurements of the affinity of d-tubocurarine, by blockade of electro-physiological response, gave values for the apparent dissociation constant in rat extensor digitorum longus muscle (innervated) of 0.039 µM, and in rat soleus (denervated) of 0.8 µM, at 23°. The results of these studies support an earlier proposal that H12-HTX blocks neuromuscular transmission by acting at a site other than the acetylcholine recognition site of the receptor.

Submitted on March 31, 1976
Accepted on June 30, 1976




This article has been cited by other articles:


Home page
ScienceHome page
E. Albuquerque, A. Eldefrawi, M. Eldefrawi, N. Mansour, and M. Tsai
Amantadine: neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor
Science, February 17, 1978; 199(4330): 788 - 790.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics